Jürgen Rödel

Prof. Dr. Jürgen Rödel


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2011 in Critical Care
Verified
Journal Article
Open access
PDF file
GOGordon P Otto
Gordon P Otto
MSMaik Sossdorf
Maik Sossdorf
RCRalf A. Claus
Ralf A. Claus
JRJürgen Rödel
Jürgen Rödel
KMKatja Menge
Katja Menge
NRNiels C Riedemann
Niels C Riedemann
Introduction: Recent models capturing the pathophysiology of sepsis and ex-vivo data from patients are speculating about immunosuppression in the so-called late phase of sepsis. Clinical data regarding survival and microbiological burden are missing. The aim of this study was to determine the clinical significance of the 'late phase' of sepsis with respect to overall survival and occurrence of microbiological findings. Methods: In a retrospective trial, 16,041 patient charts from a university intensive care unit were screened, and 999 patients with severe sepsis or septic shock were identified. Three phases were established according to the mortality peaks which were separated by two distinct nadirs: phase I (days 1 to 5), phase II (days 6 to 15) and phase III (days 16 to 150). Patients were analyzed for outcome, SOFA scores, procalcitonin levels, antimicrobial treatment, dialysis, mechanical ventilation and results of blood cultures during their hospital stay. Results: Out of 999 enrolled patients, 308 died during the course of sepsis presenting a characteristic mortality rate (30.8%) with three distinct mortality peaks (at days 2, 7 and 17). Overall 36.7% of all deaths occurred in the early phase (phase I) and 63.3% during the later phases (phase II + III). In total 2,117 blood cultures were drawn. In phase I, 882 blood cultures were drawn, representing a sampling rate of 88% with a positive rate of 14.9%. In phase II, 461 samples were taken, indicating a sampling rate of 52% and a positive rate of 11.3%. Within phase III, 524 samples were obtained representing a sampling rate of 66% with a positive rate of 15.3%, which was significantly higher compared to the positive rate of phase II and similar to phase I. In particular, the rate of typically opportunistic bacteria increased significantly from 9% in phase I up to 18% in phase III. The same is true for Candida spp. (phase I 13%, phase III 30%). Conclusions: The later phase of sepsis is associated with a significant re-increase of positive blood culture results, especially regarding opportunistic bacteria and fungi. These observations warrant further studies focusing on the underlying mechanisms resulting in this outcome burden in the later phase of sepsis.

1 November 2020 in Journal of Clinical Virology
Verified
Journal Article
Closed access
JRJürgen Rödel
Jürgen Rödel
RERenate Egerer
Renate Egerer
ASAynur Suleyman
Aynur Suleyman
BSBeatrice Sommer-Schmid
Beatrice Sommer-Schmid
MBMichael Baier
Michael Baier
BLBettina Löffler
Bettina Löffler

1 January 2012 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
JRJürgen Rödel
Jürgen Rödel
CGChristina Große
Christina Große
HYHangxing Yu
Hangxing Yu
KWKatharina Wolf
Katharina Wolf
GOGordon P. Otto
Gordon P. Otto
ESEberhard Straube
Eberhard Straube
Intracellular persistence of Chlamydia trachomatis has been implicated in the development of chronic infection that can result in pelvic inflammatory disease and tubal sterility. By inhibition of host cell apoptosis, chlamydiae have evolved a strategy to maintain the intracellular environment for replication and persistence. Both antiapoptotic host cell-derived factors and the chlamydial protease-like activity factor (CPAF) are involved in Chlamydia -mediated apoptosis resistance. Here, we show that in HeLa cells infected with gamma interferon (IFN-γ)-induced persistent C. trachomatis serovar D, the expression of CPAF is downregulated, and proapoptotic protease substrates are not cleaved. Persistent infection protected HeLa cells from apoptosis when they were exposed to staurosporine. Small-interfering RNA-mediated inhibition of myeloid cell leukemia 1 (Mcl-1) protein upregulation sensitized persistently infected cells for apoptosis. The inhibitor of apoptosis protein 2 (IAP-2) seems not to be relevant in this context because IAP-2 protein was not induced in response to IFN-γ treatment. Although apoptosis was inhibited, persistent infection caused cell membrane disintegration, as measured by the increased release of cytokeratin 18 from HeLa cells. Moreover, persistently infected cells released significantly increased amounts of high mobility group box 1 (HMGB1) protein which represents a proinflammatory damage-associated pattern molecule. The data of this study suggest that cells infected with persistent C. trachomatis are protected from apoptosis independently of CPAF but may promote chronic inflammation through HMGB1 release.

1 December 2014 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
SSSvea Sachse
Svea Sachse
SBStephanie Bresan
Stephanie Bresan
MEMarcel Erhard
Marcel Erhard
BEBirgit Edel
Birgit Edel
WPWolfgang Pfister
Wolfgang Pfister
JRJürgen Rödel
Jürgen Rödel

6 January 2017 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
JRJürgen Rödel
Jürgen Rödel
JBJ. A. Bohnert
J. A. Bohnert
SSS. Stoll
S. Stoll
LWL. Wassill
L. Wassill
BEB. Edel
B. Edel
WPW. Pfister
W. Pfister

24 January 2019 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
JRJürgen Rödel
Jürgen Rödel
AMAlexander Mellmann
Alexander Mellmann
CSClaudia Stein
Claudia Stein
MAMonika Alexi
Monika Alexi
FKFrank Kipp
Frank Kipp
ESEberhard Straube
Eberhard Straube